Improvement in hematological status and symptoms in IBD patients using ferric carboxymaltose (FERINJECT®): A German multicenter non-interventional study

Background/Aim: Anemia represents the most common systemic complication in inflammatory bowel disease (IBD). Although cause of anemia in IBD is multifactorial, iron deficiency is the most prevalent. This non-interventional study (NIS) gives insight into the current status of anemia treatment in German IBD patients by evaluating the efficacy and tolerance of i.v. iron treatment in IBD patients, considering both hematological and quality-of-life outcomes. Methods: Up to February 2010, 133 IBD patients (79 Crohn's disease [CD], 54 ulcerative colitis[CU]), mean age 36 (18–83) years, were investigated at 40 centers i…